Loading...

RenovaCare, Inc.

RCARPNK
Healthcare
Biotechnology
$0.00
$0.00(100.00%)

RenovaCare, Inc. (RCAR) Stock Overview

Explore RenovaCare, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for RCARStats details for RCAR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for RCARAnalyst Recommendations details for RCAR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.

CEO

Mr. Harmel S. Rayat

Employees

1

Headquarters

9375 East Shea Blvd, Scottsdale, AZ

Founded

1996

Frequently Asked Questions